Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
12 resultat
Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE PRESENT INVENTION
1. Field of Invention
The present invention relates to ursolic acid medicine, and more particularly, relates to freeze-dried ursolic acid nano-powder for injection as the preparation method thereof.
2. Description of Related Arts
Ursolic acid is a kind of organic
Methods and systems for treating or preventing cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Methods and systems for treating or preventing cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Methods and systems for treating or preventing cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Methods and systems for treating or preventing cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Cancer treatments and compositions for use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Cancer treatments and compositions for use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Cancer treatments and compositions for use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Sustained peptide-release formulation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
Sustained GnRH peptide-release formulation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
Sustained peptide-release formulation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
Oral formulations of kinase inhibitors
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Small-molecule inhibitors of various classes of kinases have become significant exploratory medicinal compounds. However, certain kinase inhibitors possess properties of low water solubility and poor oral bioavailability.
Among the various classes of kinases for which experimental
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
